AAA	Abdominal aortic aneurysm
ACCORD-Lipid study	Action to Control Cardiovascular Risk in Diabetes (ACCORD)-Lipid study
ACS	Acyl-CoA synthase
ALP	Alkaline phosphatase
ALT	Alanine aminotransferase
Apo	Apolipoprotein
ASCVD	Atherosclerotic cardiovascular diseases
AUC	Area under the curve
BIP study	Bezafibrate Infarction Prevention study
CKD	Chronic kidney disease
CV	Cardiovascular
eGFR	Estimated glomerular filtration rate
eNOS	Endothelial nitric oxide synthase
FGF21	Fibroblast growth factor 21
FIELD study	Fenofibrate Intervention and Event Lowering in Diabetes study
GP-HPLC	Gel-permeation high-performance liquid chromatography
γ-GT	Gamma-glutamyl transferase
HDL-C	High-density lipoprotein-cholesterol
HHS	Helsinki Heart Study
HOMA-IR	Homeostasis model assessment for insulin resistance
IAS	International Atherosclerosis Society
JAS	Japan Atherosclerosis Society
LDL-C	Low-density lipoprotein-cholesterol
LPL	Lipoprotein lipase
MRE	Magnetic resonance elastography
MRI-PDFF	MRI-estimated proton density fat fraction
NAFLD	Nonalcoholic fatty liver disease
NASH	Nonalcoholic steatohepatitis
PBC	Primary biliary cholangitis
PCSK9	Proprotein convertase subtilisin/kexin type 9
PPAR α	Peroxisome proliferator-activated receptor α
PROMINENT	Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes
RemL-C	Remnant lipoprotein-cholesterol
R3i Foundation	Residual Risk Reduction Initiative (R3i) Foundation
TG	Triglyceride
VLDL	Very-low-density lipoprotein